Prenatal diagnosis of Noonan syndrome in fetuses with increased nuchal translucency and a normal karyotype

Česká verzia

Authors: M. Matyášová ¹; Z. Dobšáková ¹; M. Hiemerová ¹; J. Kadlecová ¹; D. Nikulenkov Grochová ¹; E. Popelínská ¹; E. Svobodová ¹; P. Vlašín ²
Authors place of work: Cytogenetická laboratoř Brno, s. r. o, vedoucí laboratoře RNDr. E. Popelínská ¹; Centrum prenatální diagnostiky Brno, s. r. o, jednatelé MUDr. P. Vlašín a MUDr. M. Čuprová ²
Published in the journal: Ceska Gynekol 2019; 84(3): 195-200
Category:

Summary

Objective: Noonan syndrome (NS), one of the most common RASopathies, has an estimated incidence of 1 in 1,000–2,500 live births. In the prenatal period increased nuchal translucency, hygroma colli, hydrops fetus, congenital heart disease, kidney defects, larger amount of amniotic fluid can be observed in affected fetuses with this syndrome. In the fetuses with normal karyotype and no microdeletion/microduplication syndromes the examination of selected genes for RASopathies was added. The aim of the study was to evaluate the clinical benefit of massively parallel sequencing (MPS) of susceptible fetal DNA for NS, i.e., the diagnostic yield on the one hand and the proportion of detected variants of unknown significance (VOUS) on the other.

Design: Clinically diagnostic.

Setting: Centrum prenatální diagnostiky, Brno, s.r.o; Cytogenetická laboratoř Brno, s.r.o.

Methods: Samples of amniotic fluid or chorionic villus were analyzed. Selected genes associated with RASopathies were analyzed in case of the negative result of karyotype and array-CGH. A panel of twenty genes was investigated by MPS.

Results: In the two-years period, Noonan syndrome was detected in 10 from 95 investigated fetuses. This represents a 10.5% diagnostic efficiency of the method. DNA variants of unknown significance were detected in 10 fetuses. A segregation analysis helped to clarify their meaning in six fetuses.

Conclusion: MPS allows fast molecular-genetic diagnosis of RASopathies already in the prenatal period. This method contributes to the clarification not only of phenotypic manifestations in already born individuals but also of ultrasound findings in fetuses with both normal karyotype and aCGH.

Keywords:

RASopathies – Noonan syndrome – nuchal translucency – NT – fetal hydrops – cystic hygroma – heart defect – massively parallel sequencing – MPS

Zdroje

1. Ali, MM., Chasen, ST., Norton, ME. Testing for Noonan syndrome after increased nuchal translucency. Prenatal Diagnosis, 2017, 37, p. 750–753.

2. Aoki, Y., Niihori, T., Inoue, S., Matsubara, Y. Recent advances in RASopathies. J Hum Genet, 2016, 61, p. 33–39.

3. Croonen, EA., Nillesen, WM., Stuurman, KE., et al. Prenatal diagnostic testing of the Noonan syndrome genes in fetuses with abnormal ultrasound findings. Eur J Hum Gen, 2013, 21, p. 936–942.

4. Hernández-Martín, A., Torrelo, A. Rasopathies: developmental disorders that predispose to cancer and skin manifestations. Actas Dermosifiliograf, 2011, 102, p. 402–416.

5. Chen, P., Yin, J., Yu, H., et al. Next-generation sequencing identifies rare variants associated with Noonan syndrome. PNAS, 2014, 111(31), p. 11473–11478.

6. Lee, KA., Williams, B., Roza, K., et al. PTPN11 analysis for the prenatal diagnosis of Noonan syndrome in fetuses with abnormal ultrasound findings. Clin Genet, 2009, 75, p. 190–194.

7. Loucký, J., Springer, D., Zima, T. Možnosti screeningu Downova syndromu v České republice. Čes Gynek, 2008, 73(3), p. 160–162.

8. Milosavljević, D., Overwater E., Tamminga, S., et al. Two cases of RIT1 associated Noonan syndrome: further delineation of the clinical phenotype and review of the literature. AJMG, part A. 2016, p. 1874–1880.

9. OMIM – Online mendelian inheritance in man. [online]. 2018. [cit. 2018-10-15]. Dostupné z: http://www.omim.org/.

10. Rauen, KA. The RASopathies. Ann Rev Genomics. Hum Genet, 2013, 14, p. 355–369.

11. Richards, S., Aziz, N., Bale, S., et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendattion of the American college of medical genetics and genomics and the association for the molecular pathology. Genet Med, 2015, p. 1–20.

12. Sonek, JD., Nicolaides, KH., Janků, P. Screening v 11.–13.+6 týdnu těhotenství. Čes Gynek, 2012, 77(2). p. 92–104.

Štítky

Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine Paediatric cardiology Endocrinology Paediatrics General practitioner for children and adolescents

Článek Individualization of surgical management of cervical cancer stages IA1, IA2

Článek Endometrial Receptivity Analysis – a tool to increase an implantation rate in assisted reproduction

Článek NK cells not only in endometrium but also in ovulatory cervical mucus in patients with decreased fertility

Článek Echogenic foci in fetal heart from a pediatric cardiologist‘s point of view

Článek Locally advanced colorectal cancer in pregnancy

Článek Primary synovial sarcoma of the ovary and Fallopian tube – case report and review of the literature

Článek The changes in FIGO staging for carcinoma of the cervix uteri

Článek Impact of 3D ultrasound on fetal CNS examination

Článek The risk of thromboembolism in relation to in vitro fertilization

Článek Vaginismus – who takes interest in it?

Článek Uterine adenomyosis: pathogenesis, diagnostics, symptomatology and treatment

Článek Comparison of obstetrical interventions in women with vaginal and cesarean section delivered: cross-sectional study in a reference tertiary center in the Northeast of Brazil